System Labs Review 2026: Prices, Products and Terms

System Labs publishes a price on every product page, with no login and no insurance check. Read the small type on the number: most headline figures are a first-month rate, struck through against the regular rate they renew to. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before marketing.

The catalogue is eight compounded products in four routes — injection, nasal spray, oral tablet and topical foam — covering sermorelin, NAD+, glutathione, MIC+B12 and GHK-Cu. System Labs does not sell GLP-1 weight-loss medication. No semaglutide or tirzepatide page exists, and the September 2026 press release names only “Glutathione, MIC+B12, NAD+, and Sermorelin”.

Compounded drugs are not FDA-approved. In FDA’s words, “Compounded drugs are not reviewed by the agency for safety, effectiveness or quality prior to marketing.”

Sermorelin, injection and oral tablet. An approved product once existed: GEREF, approved in 1990 and 1997, discontinued in 2008 and withdrawn effective 18 June 2009 — “not withdrawn for reasons of safety or effectiveness”. Either way, no FDA-approved sermorelin is marketed in the US today. No oral sermorelin has ever been approved; the company names its own product “Oral Compounded Sermorelin”.

NAD+, glutathione and GHK-Cu. None of the three has an approved drug product. NAD and glutathione sit in Category 1 of the bulk substances nominated for use in 503A compounding, still under FDA evaluation, as does “GHK-Cu (except for injectable routes of administration)” — so the topical route sold here is the one under evaluation. Nominated is not approved.

MIC+B12. The composition is “Methionine, Inositol, Choline, and B12”. B12 alone has an approved counterpart, cyanocobalamin injection, USP under ANDA080515, but for a narrow use: “vitamin B12 deficiencies due to malabsorption”. The four-ingredient combination is not approved, and the uses marketed here (fat metabolism, energy, liver function) are not that indication.

So nothing here has a marketed FDA-approved counterpart. Claims such as NAD+ “Supports cellular energy production and reduces fatigue” are the company’s own, and its “3rd Party lab tested” line names no laboratory. Background: our guide to 503A and 503B compounding pharmacies.

Credit where it is due. Much of this category buries the regulatory position. System Labs runs the same block on the homepage, the protocol page and every product page we read:

“The peptide medications and therapies offered have not been approved by the FDA. The FDA has not evaluated statements regarding benefits of these therapies.”

It adds that the products “are not intended to diagnose, treat, cure, or prevent any disease.” Three pages — glutathione, glutathione nasal spray and oral sermorelin — carry one more line: “Use of compounded medications involves known and unknown risks that should be discussed with your clinician.” That is more than many competitors publish.

One note on placement: it sits in the footer, not beside the benefit copy. Read it on the page you are buying from, then take that risks line into the chat with the clinician.

Prescribing is described but not attributed: “Clinical services are provided by licensed clinicians” in the terms, and “Board-certified clinician prescribes a custom peptide protocol” on the protocol page. No medical group, clinician name or state licence number is published anywhere.

Dispensing is disclosed better than most. The terms name the pharmacy: products are “dispensed and distributed by independent third-party pharmacies, including The Pharmacy Hub”. “Including” means others may be used and are not named, and System Labs has “no ownership, control, or operational oversight” over them. The Pharmacy Hub gives its location as “Miami, Florida, USA”.

The operator is “System Laboratories, Inc.” at “564 Market St, San Francisco, CA 94104”. Its privacy policy, dated January 28, 2026, puts HIPAA on the pharmacies, which are “bound by their own privacy policies and applicable pharmacy regulations, including HIPAA where applicable.” A press release of September 9, 2026 announced a “$20 million” round, naming Adam Steinle as founder and CEO.

Ask the clinician who contacts you for their name and state licence.

The intake is the fastest part: “Select your treatment. Fill out a 2-minute form. No appointment needed.” The protocol page adds “No clinic visit required”. You must be “at least 18 years of age to use this Site”.

Everything is asynchronous. After the form, “A licensed provider reviews your info and reaches out via chat.” No live video or phone visit is described anywhere. Follow-up appears once, as “Quarterly recalibration consults” inside the membership.

On geography the site publishes nothing: no state list, no selector, no exclusions on the homepage, either index, the terms, the privacy policy or the contact page. The only geographic statement we found is a press-release line: “Available in all 50 U.S. states, subject to state telehealth regulations”.

Delivery is free and quick: “Free shipping” and “No insurance required” on product pages, “2-day shipping” on the homepage and “2-day temp-controlled shipping” on the membership page. Email support@systemlabs.com before you start and ask two things: do you serve my state, and do I need labs.

The refund terms are short. For health and safety reasons, “all sales of prescription medications and other products are final once the product has been processed and shipped by our partner pharmacy.” The terms add: “We are unable to accept returns or issue refunds for shipped medications or other products.” No refund window or trial period appears in them.

On cancellation the terms give one window: “You may cancel an order at any time before your prescription is sent to our partner pharmacy for fulfillment,” and “If an order is canceled before this stage, you will not be billed.” The peptide-therapy page puts it differently: “Pause or cancel anytime”. The two do not agree and the site does not reconcile them, so we print both. The FAQ headings for refunds and cancellation exist, but those answers did not reach our fetcher.

On renewal the terms are silent: no auto-renewal clause, no renewal price, no billing interval, no cancellation procedure. Disputes go to “binding arbitration, rather than in court” with a class-action waiver, and liability is capped at $100.

Before the first charge, ask support for the renewal date, the second charge and the step that stops it. See how we review.

Read together: no enforcement history we could find, and very little history of any kind — the BBB file is weeks old, and the one consumer-review profile is gone.